Dr Fiorita Poulakaki (Athens Medical Centre Hospital, Athens, Greece) and Dr Michail Ignatiadis (Institut Jules Bordet, Brussels, Belgium) discuss the recommendations from the EBCC 2024 manifesto session.

The manifesto session's main aim was to address inequalities across Europe in access to innovation for patients with metastatic breast cancer.

The manifesto was divided into four categories: stigma, registries and real-world data, multidisciplinary care, and quality indicators.

The panellists highlight the seven recommendations from this session.